NasdaqCM - Nasdaq Real Time Price USD

Baird Medical Investment Holdings Limited (BDMD)

0.1604 -0.0276 (-14.68%)
At close: October 30 at 4:00:01 PM EDT
0.1451 -0.0153 (-9.54%)
After hours: October 30 at 7:55:59 PM EDT
Chart Range Bar
Loading chart for BDMD
  • Previous Close 0.1880
  • Open 0.1800
  • Bid 0.1420 x 100
  • Ask 0.1578 x 100
  • Day's Range 0.1333 - 0.2700
  • 52 Week Range 0.1330 - 3.7000
  • Volume 9,525,692
  • Avg. Volume 248,784
  • Market Cap (intraday) 5.151M
  • Beta (5Y Monthly) -1.12
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5500
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 4.00

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. It has a strategic cooperation agreement with Tianjin Yuanshan Medical Technology Co., Ltd. to focus on global development and commercialization of next-generation IRE technologies. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

bairdmed.com

146

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BDMD
88.21%
S&P 500 (^GSPC)
10.73%

1-Year Return

BDMD
88.54%
S&P 500 (^GSPC)
11.11%

3-Year Return

BDMD
98.49%
S&P 500 (^GSPC)
81.91%

5-Year Return

BDMD
98.37%
S&P 500 (^GSPC)
64.59%

Analyst Insights

View More

Analyst Price Targets

4.00
4.00 Average
0.1604 Current
4.00 High
 

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    5.15M

  • Enterprise Value

    23.74M

  • Trailing P/E

    --

  • Forward P/E

    1.15

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    0.20

  • Price/Book (mrq)

    0.15

  • Enterprise Value/Revenue

    0.97

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -65.12%

  • Return on Assets (ttm)

    -11.88%

  • Return on Equity (ttm)

    -46.03%

  • Revenue (ttm)

    24.49M

  • Net Income Avi to Common (ttm)

    -15.95M

  • Diluted EPS (ttm)

    -0.5500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    397.19k

  • Total Debt/Equity (mrq)

    54.52%

  • Levered Free Cash Flow (ttm)

    22.44M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.1604 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

People Also Watch